Mon. 18 Mar 2024, 7:19am ET
Benzinga
Earnings, News
Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.55) by 16.36 percent. This is a 58.18 percent increase over losses of $(1.10) per share from the same period last year.